- Sun Pharma chairman Israel Makov to retire on 29 August 08 August 2022
- Sun Pharma swings to Q2 net profit of Rs1,062 cr 07 November 2019
- Sun Pharma licenses AstraZeneca to sell its oncology drugs in China 06 November 2019
- Sun Pharma's Q3 net profit vaults 49% to Rs1,242 crore 13 February 2019
- Sun Pharma gets US FDA clearance for its Halol plant 13 June 2018
- Sun Pharma acquires Novartis' oncology brand Odomzo 22 December 2016
- Sun asks US FDA to withdraw nod for 28 Ranbaxy ANDAs 20 December 2016
- Sun Pharma Q2 net surges 117% to Rs2,235 cr 10 November 2016
- Dr Reddy's, Sun Pharma under cartelisation probe in US 05 November 2016
- Sun Pharma gets US subpoena over drugs pricing 30 May 2016
- Sun Pharma in pact to develop brain stroke drug 11 December 2015
- Sun Pharma gets US nod for generic leukemia drug 05 December 2015
- Sun Pharma in talks to buy Novartis' Japan portfolio 14 November 2015
- ICRA gives triple-A ratings to Sun's borrowing plans 14 November 2015
- Sun Pharma completes acquisition of InSite Vision 03 November 2015
- US FDA rescinds approval for Sun Pharma's epilepsy drug Elepsia XR 26 September 2015
- Sun Pharma sells two Ranbaxy units to Strides Arcolab 21 September 2015
- Sun Pharma to acquire US firm InSite Vision for $48 mn 18 September 2015
- Daiichi Sankyo begins selling its stake in Sun Pharma 21 April 2015
- Sun, Ranbaxy complete $4-bn merger 24 March 2015
- Sun-Ranbaxy merger deal nears closure with HC nod 09 March 2015
- Sun Pharma to buy Glaxo's Australian opiates business 03 March 2015
- Suzlon Energy confirms 23% stake sale to Sun's Shanghvi 14 February 2015
- Sun's Shanghvi reported in talks with Tanti for Suzlon stake 13 February 2015
- Sun Pharma buyout of Ranbaxy gets conditional US nod 31 January 2015
- Sun Pharma, Ranbaxy merger deal gets conditional CCI nod 09 December 2014
- Sun Pharma hopes to turn around Ranbaxy in four years of closing deal 12 September 2014
- Competition panel seeks public comments on Sun-Ranbaxy merger deal 04 September 2014
- CCI worried about 'molecular' effect of Sun-Ranbaxy merger 30 August 2014
- Sun-Ranbaxy merger: competition panel demands more details 28 August 2014
- Sun Pharma unit recalls Cephalexin capsules in US market 16 August 2014
- SC blasts manner of stalling Sun-Ranbaxy merger 21 May 2014
- Ranbaxy drug flows to Europe, US to dry up 09 April 2014
- Sun Pharma, Ranbaxy to merge in Rs24,000 all-stock deal 07 April 2014
- And now, USFDA bans imports from Sun Pharma unit 13 March 2014
- Sun Pharma Q2 net jumps four-fold to Rs1,362 crore 14 November 2013
- Sun Pharma does well, but Pfizer settlement puts it in red 10 August 2013
- Sun Pharma gets US nod to sell generic diabetes drug 13 July 2013
- Sun Pharma calls off $600-million buyout of Taro 08 February 2013
- Sun Pharma's US unit to buy URL Pharma 18 December 2012
- Sun Pharma to buy out Israel's Taro for $571 million 13 August 2012
- Sun Pharma resolves FDA issue at US plant 19 September 2011
- Sun to co market Merck's Diabetes drugs in India 25 April 2011
- Merck, Sun Pharma in generics JV 11 April 2011
- US FDA grants tentative approval for Sun's generic Aricept 30 November 2010
- Sun Pharma receives tentative USFDA approval for generic Crestor 30 September 2010
- Sun Pharma board approves stock split into Re1 shares 24 September 2010
- Sun acquires controlling stake in Taro, Shanghvi is chairman 22 September 2010
- Israel Supreme Court lifts injunction on Sun's acquisition of Taro 08 September 2010
- USFDA approves Sun's generic version of Lilly's Strattera 01 September 2010
- Taro case: US court rules in favour of Sun Pharma 15 July 2010
- Sun Pharma's epilepsy drug granted US FDA approval 17 June 2010
- Sun Pharma gets USFDA approval for generic Prometh syrup 18 March 2010
- Sun fails to dislodge Taro directors at general body 01 January 2010
- Glass Lewis supports Sun in Taro battle 23 December 2009
- Templeton cold to Taro's plea for protection against Sun 22 December 2009
- Sun Pharma advises Taro shareholders against voting at AGM 18 December 2009
- Taro again warns shareholders to stay away from Sun 12 December 2009
- Templeton switches sides; backs Sun on Taro takeover 02 December 2009
- Sun Pharma gets FDA nod for selling generic drug 27 November 2009
- Israeli drug firm Taro sues Sun Pharma in US 30 September 2009
- Sun Pharma settles Ethyol dispute with MedImmune 03 August 2009
- Sun Pharma puts up brave face after FDA crackdown 27 June 2009
- Sun Pharma's US arm acquires Chattem 27 November 2008
- Sun Pharmaceutical buys Taro Pharma shares from Brandes 20 February 2008
- Sun Pharma launches generic version of Wyeth's Protonix 30 January 2008
- Sun Pharma announces settlement of litigation over generic Exelon 06 December 2007
- Ranbaxy follows Sun Pharma in demerging R&D business 19 October 2007
- Impressive results by Sun Pharma 31 October 2005
- Sun Pharma to buy manufacturing site in Hungary 11 August 2005
- Sun Pharma to issue $75 million FCCB 06 December 2004
- Sun Pharma launches $225 million FCCB 19 November 2004
- Sun Pharmaceuticals proposes share swap with Phlox Pharma 03 August 2004
- Sun Pharma plants get US regulatory clearance 28 May 2004
- Two Sun Pharma units gets USFDA approval 27 May 2004
- Sun Pharma increases holding in Caraco 16 March 2004
- Sun Pharma to increase holdings in Caraco to 60 per cent 09 February 2004
- Sun Pharma logs healthy growth 03 February 2004
- Sun Pharmaceuticals approves resolutions for split, buyback 21 December 2002
- Sun Pharma clocks 12% turnover, 14% PAT increase in Q2 29 October 2002
- DCI team clears Sun Pharma research facility 18 September 2002
- Sun Pharma sales, profit up; dividend at 50% 01 June 2002
- Sun Pharma meet on merger with MJ Pharma 27 May 2002
- Sun Pharma commissions Dadra plant 30 March 2002
- Caraco gets FDA nod for a drug 09 January 2002
- Explosion at Sun Pharma lab 08 January 2002
- Sildenafil citrate drug sales surge 05 December 2001
- Sun Pharma launches cure for smoking 14 August 2001
- Will the ‘Sun’ rise on Caraco Pharmaceuticals? 10 April 2001
- Sun Pharma announces 1:500 share swap for Pradeep Drugs 27 February 2001
- Sun Pharma plans to take over Pradeep Drugs 16 February 2001
